TAO Synergies TAOX
NASDAQ TAOX
$4.13 +0.12 (+2.99%)
As of: Sep 9, 2026 · 2:42 PM EDT

TAO Synergies (TAOX) Prepaid Assets (2019 - 2026)

TAO Synergies' (TAOX) quarterly Prepaid Assets came in at $1.4 million in Q2 2026, up 56.2% on a YoY basis from $921349.0 in Q2 2025, and little changed quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Prepaid Assets (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Prepaid Assets for 8 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets rose 56.2% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $1.4 million (up 56.2% YoY), and the FY2025 full-year result was $2.0 million, up 2923.07% from the prior year.
  • Prepaid Assets was little changed at $1.4 million in Q2 2026 per TAOX's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.0 million in Q4 2025 and bottomed at $57677.0 in Q4 2023.
  • Historically, Prepaid Assets has averaged $702890.7 across 5 years, with a median of $541808.5 in 2022.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 92.2% in 2023, then jumped 2923.07% in 2025.
  • Over 5 years, Prepaid Assets stood at $739467.0 in 2022, then plunged by 92.2% to $57677.0 in 2023, then gained by 12.06% to $64633.0 in 2024, then surged by 2923.07% to $2.0 million in 2025, then retreated by 26.34% to $1.4 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.4 million, $1.4 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn
10 TAO Synergies 30.86 Mn 30.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Mn
Mar 31, 2026 1.44 Mn
Dec 31, 2025 1.95 Mn
Sep 30, 2025 1.52 Mn
Jun 30, 2025 921,349.00
Mar 31, 2025 484,153.00
Dec 31, 2024 64,633.00
Sep 30, 2024 211,230.00
Jun 30, 2024 411,150.00
Mar 31, 2024 560,583.00
Dec 31, 2023 57,677.00
Sep 30, 2023 238,109.00
Jun 30, 2023 385,769.00
Mar 31, 2023 586,364.00
Dec 31, 2022 739,467.00
Sep 30, 2022 395,342.00
Jun 30, 2022 523,034.00
Mar 31, 2022 720,211.00
Dec 31, 2021 879,869.00
Sep 30, 2021 1.05 Mn